CRISPR-Edited T Cells Used in Cancer Patients for the First Time in the US
CRISPR-Edited T Cells Used in Cancer Patients for the First Time in the US
The initial findings from a small clinical trial of patients with multiple myeloma or sarcoma suggest that gene-edited immunotherapy is safe.
CRISPR-Edited T Cells Used in Cancer Patients for the First Time in the US
CRISPR-Edited T Cells Used in Cancer Patients for the First Time in the US

The initial findings from a small clinical trial of patients with multiple myeloma or sarcoma suggest that gene-edited immunotherapy is safe.

The initial findings from a small clinical trial of patients with multiple myeloma or sarcoma suggest that gene-edited immunotherapy is safe.

sarcoma
Image of the Day: Van Gogh Microscopy
Image of the Day: Van Gogh Microscopy
The Scientist Staff, The Scientist Staff | Jan 10, 2018
Scientists identify the cells that give rise to the soft tissue cancer rhabdomyosarcoma. 
Fighting Cancer with Infection, 1891
Fighting Cancer with Infection, 1891
Catherine Offord | Apr 1, 2016
Now hailed as the father of immunotherapy, William Coley pioneered extraordinary methods to treat cancer.